Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Pierre Fabre Médicament - IRPF
Woman and Man Max 99 years
Pierre Fabre Médicament - IRPF
Update Il y a 4 ans
Exploratory study of the efficacy and safety of flexible doses of Milnacipran and Venlafaxine administered in out patients with Major Depressive Disorder
- To assess the percentage of responders in both treatment groups, Milnacipran or Venlafaxine administered up to 200 mg/day in flexible doses, during a treatment period of 8 weeks including up-titrati...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Pierre Fabre Médicament - IRPF
Update Il y a 4 ans
EFFECT OF V0251 IN ACUTE VERTIGO. A RANDOMISED DOUBLE-BLIND PLACEBO CONTROLLED STUDY
The primary objective of the study is to determine the efficacy of one single intravenous injection of 4g of V0251 on vertigo symptoms relief in patient presenting with an attack of acute vertigo from...
Country
None
organs
None
Specialty
None
Closed trial
More information